JMP Securities assumed coverage on shares of Addus HomeCare (NASDAQ:ADUS - Free Report) in a report released on Monday, Marketbeat.com reports. The firm issued an outperform rating and a $150.00 price target on the stock.
Other analysts also recently issued research reports about the stock. StockNews.com upgraded shares of Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Wednesday, December 11th. Stephens raised their price target on Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 6th. Macquarie reissued an "outperform" rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. Oppenheimer lifted their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a report on Monday, September 23rd. Finally, KeyCorp began coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an "overweight" rating and a $150.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Addus HomeCare presently has a consensus rating of "Moderate Buy" and an average target price of $133.67.
Get Our Latest Stock Analysis on ADUS
Addus HomeCare Stock Performance
Shares of ADUS stock traded up $5.41 during trading hours on Monday, reaching $130.41. The company had a trading volume of 367,170 shares, compared to its average volume of 131,622. The stock has a fifty day moving average of $125.64 and a 200-day moving average of $124.55. The company has a market capitalization of $2.36 billion, a price-to-earnings ratio of 28.60, a PEG ratio of 2.11 and a beta of 1.01. Addus HomeCare has a 12-month low of $85.94 and a 12-month high of $136.12.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm's revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.03 earnings per share. On average, analysts forecast that Addus HomeCare will post 4.59 EPS for the current year.
Insiders Place Their Bets
In related news, CEO R Dirk Allison sold 12,500 shares of the business's stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the sale, the chief executive officer now owns 141,897 shares of the company's stock, valued at $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the company. Connor Clark & Lunn Investment Management Ltd. acquired a new position in Addus HomeCare in the third quarter worth approximately $1,622,000. Dimensional Fund Advisors LP lifted its stake in shares of Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company's stock valued at $82,930,000 after purchasing an additional 5,421 shares during the last quarter. Argent Capital Management LLC boosted its holdings in Addus HomeCare by 51.5% in the second quarter. Argent Capital Management LLC now owns 37,310 shares of the company's stock worth $4,332,000 after purchasing an additional 12,685 shares in the last quarter. Point72 Asset Management L.P. boosted its stake in shares of Addus HomeCare by 73.4% during the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company's stock worth $86,598,000 after acquiring an additional 315,602 shares in the last quarter. Finally, Victory Capital Management Inc. increased its holdings in shares of Addus HomeCare by 136.5% during the 2nd quarter. Victory Capital Management Inc. now owns 80,047 shares of the company's stock valued at $9,294,000 after acquiring an additional 46,199 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.
Addus HomeCare Company Profile
(
Get Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Further Reading
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.